[
  {
    "bcr_patient_uuid": "5AEAC31A-176A-4F93-A376-A93A670821BB",
    "patient_ID": "TCGA.2W.A8YY",
    "bcr_drug_barcode": "TCGA-2W-A8YY-D58309",
    "bcr_drug_uuid": "14ACEFE0-DDC0-4A31-B354-D0A304A6C773",
    "form_completion_date": "2014-5-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 57,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "14c65927-b9dd-4ef6-9917-db7bc431ff2f",
    "patient_ID": "TCGA.C5.A0TN",
    "bcr_drug_barcode": "TCGA-C5-A0TN-D30749",
    "bcr_drug_uuid": "1E4E1C91-1CF4-4AE9-A35F-599B3586D121",
    "form_completion_date": "2012-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "2b6d2c15-8bcc-41ab-84d6-601442f4378b",
    "patient_ID": "TCGA.C5.A1BE",
    "bcr_drug_barcode": "TCGA-C5-A1BE-D30509",
    "bcr_drug_uuid": "A715C97A-30BE-41EA-8E32-FC40D47180B1",
    "form_completion_date": "2012-4-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1666,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "2b6d2c15-8bcc-41ab-84d6-601442f4378b",
    "patient_ID": "TCGA.C5.A1BE",
    "bcr_drug_barcode": "TCGA-C5-A1BE-D30508",
    "bcr_drug_uuid": "778DACD3-1169-4B7A-8A3B-E324986427D3",
    "form_completion_date": "2012-4-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "262311a0-7a10-4934-8fba-11ee581ad738",
    "patient_ID": "TCGA.C5.A1BF",
    "bcr_drug_barcode": "TCGA-C5-A1BF-D30724",
    "bcr_drug_uuid": "484070B1-FD8E-46A3-B031-DA66D5641485",
    "form_completion_date": "2012-4-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 181,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "91310434-2a99-4e1d-81e6-3d58d097089f",
    "patient_ID": "TCGA.C5.A1BI",
    "bcr_drug_barcode": "TCGA-C5-A1BI-D30513",
    "bcr_drug_uuid": "CD5F4D29-A387-4D5D-AC20-A519665F404D",
    "form_completion_date": "2012-4-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "8a4da4f0-30f2-497e-8a7c-988fd6b813cb",
    "patient_ID": "TCGA.C5.A1BN",
    "bcr_drug_barcode": "TCGA-C5-A1BN-D30415",
    "bcr_drug_uuid": "79519932-2069-4484-8A3C-2B29A74C417D",
    "form_completion_date": "2012-4-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 67,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "E77C3F70-08D1-40D3-B038-F09A519423CC",
    "patient_ID": "TCGA.C5.A1BQ",
    "bcr_drug_barcode": "TCGA-C5-A1BQ-D34132",
    "bcr_drug_uuid": "A9F43408-7749-4CDF-9C60-6D3B1C4AE50F",
    "form_completion_date": "2012-7-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 11,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 47,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "825a6fbb-aede-436f-800b-c7f096da0a77",
    "patient_ID": "TCGA.C5.A1M6",
    "bcr_drug_barcode": "TCGA-C5-A1M6-D29218",
    "bcr_drug_uuid": "90E18313-1409-40E4-AF66-1ED55A60D35B",
    "form_completion_date": "2012-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "drug_cycles": 6,
    "drug_units": "MG/M2/DAY",
    "drug_dose": 10,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "825a6fbb-aede-436f-800b-c7f096da0a77",
    "patient_ID": "TCGA.C5.A1M6",
    "bcr_drug_barcode": "TCGA-C5-A1M6-D33208",
    "bcr_drug_uuid": "C82C2709-144B-4A16-A2AB-5A74C1C6427D",
    "form_completion_date": "2012-6-22",
    "pharmaceutical_therapy_drug_name": "BLEOMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "825a6fbb-aede-436f-800b-c7f096da0a77",
    "patient_ID": "TCGA.C5.A1M6",
    "bcr_drug_barcode": "TCGA-C5-A1M6-D33209",
    "bcr_drug_uuid": "8437E363-F915-4549-9B5A-B5E612653094",
    "form_completion_date": "2012-6-22",
    "pharmaceutical_therapy_drug_name": "VINCRISTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "825a6fbb-aede-436f-800b-c7f096da0a77",
    "patient_ID": "TCGA.C5.A1M6",
    "bcr_drug_barcode": "TCGA-C5-A1M6-D33210",
    "bcr_drug_uuid": "1D46A633-9DAF-4335-BD53-C5D30B1E79B0",
    "form_completion_date": "2012-6-22",
    "pharmaceutical_therapy_drug_name": "MITOMYCIN C",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "825a6fbb-aede-436f-800b-c7f096da0a77",
    "patient_ID": "TCGA.C5.A1M6",
    "bcr_drug_barcode": "TCGA-C5-A1M6-D33211",
    "bcr_drug_uuid": "37FC5233-BCCA-45AA-BCC1-7312562622AC",
    "form_completion_date": "2012-6-22",
    "pharmaceutical_therapy_drug_name": "HYDROCORTISONE",
    "pharmaceutical_therapy_type": "HORMONE THERAPY",
    "days_to_drug_start": 341,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 489,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "a3be445a-a592-4073-815b-47ae41f9c4a0",
    "patient_ID": "TCGA.C5.A1M9",
    "bcr_drug_barcode": "TCGA-C5-A1M9-D29231",
    "bcr_drug_uuid": "C5BFBED2-5160-4123-87EF-9FC20F4C7FC1",
    "form_completion_date": "2012-3-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "a3be445a-a592-4073-815b-47ae41f9c4a0",
    "patient_ID": "TCGA.C5.A1M9",
    "bcr_drug_barcode": "TCGA-C5-A1M9-D29255",
    "bcr_drug_uuid": "50E2A9E4-9469-4FB3-83A2-6C425255B6EB",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 555,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METASTATIC"
  },
  {
    "bcr_patient_uuid": "3143822c-66c4-4b58-8d29-e92d065ff049",
    "patient_ID": "TCGA.C5.A1MH",
    "bcr_drug_barcode": "TCGA-C5-A1MH-D29284",
    "bcr_drug_uuid": "DEB8FE59-1B43-48EE-AD48-8F8D46FC5F71",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 8,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 65,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "3143822c-66c4-4b58-8d29-e92d065ff049",
    "patient_ID": "TCGA.C5.A1MH",
    "bcr_drug_barcode": "TCGA-C5-A1MH-D29287",
    "bcr_drug_uuid": "35858E07-7A94-4FB6-AB9E-C355907B7DF2",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1036,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "METASTATIC"
  },
  {
    "bcr_patient_uuid": "941f75a1-fea4-4539-ba69-60bb11608f6d",
    "patient_ID": "TCGA.C5.A1MI",
    "bcr_drug_barcode": "TCGA-C5-A1MI-D29735",
    "bcr_drug_uuid": "DFEB8D3B-38B3-424F-B0C9-9586D927E8D1",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 812,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE"
  },
  {
    "bcr_patient_uuid": "941f75a1-fea4-4539-ba69-60bb11608f6d",
    "patient_ID": "TCGA.C5.A1MI",
    "bcr_drug_barcode": "TCGA-C5-A1MI-D29734",
    "bcr_drug_uuid": "808E6711-8841-41A0-8B0F-DA0DD4B537CC",
    "form_completion_date": "2012-3-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 76,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "drug_cycles": 6,
    "drug_units": "MG/M2/WK",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "b726f18b-b996-4978-9f27-b3a540e06270",
    "patient_ID": "TCGA.C5.A1MK",
    "bcr_drug_barcode": "TCGA-C5-A1MK-D30184",
    "bcr_drug_uuid": "2B5D6306-B757-4481-AAFD-9C8DBDBBECFB",
    "form_completion_date": "2012-4-4",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 74,
    "drug_cycles": 5,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "287ce10e-31c8-4b10-9858-6e45451dfbe4",
    "patient_ID": "TCGA.C5.A1MN",
    "bcr_drug_barcode": "TCGA-C5-A1MN-D30193",
    "bcr_drug_uuid": "7B3A715D-196B-44E7-9A3B-BD3C3DA17A09",
    "form_completion_date": "2012-4-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 25,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "eb59cf69-1997-41b9-bf69-69ad7da292a1",
    "patient_ID": "TCGA.C5.A1MQ",
    "bcr_drug_barcode": "TCGA-C5-A1MQ-D31341",
    "bcr_drug_uuid": "AA6B4B82-7328-43D8-809B-164E794CE799",
    "form_completion_date": "2012-4-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 99,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 70
  },
  {
    "bcr_patient_uuid": "FB66B7F5-22CA-4D4D-97C2-30E6EDFFF781",
    "patient_ID": "TCGA.C5.A2LT",
    "bcr_drug_barcode": "TCGA-C5-A2LT-D21298",
    "bcr_drug_uuid": "D103CCB4-91ED-4A27-861D-D1AED78A279E",
    "form_completion_date": "2012-2-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 152,
    "drug_cycles": 6,
    "drug_units": "MG/M2/WK",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "B82F4C6D-530F-4B0E-8F33-995633CB254A",
    "patient_ID": "TCGA.C5.A2LX",
    "bcr_drug_barcode": "TCGA-C5-A2LX-D21317",
    "bcr_drug_uuid": "85A0C61D-EA35-4F65-96E7-BA0F109F33E8",
    "form_completion_date": "2012-2-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 77,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "drug_cycles": 6,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "E733F289-A0EC-478C-AAD9-1378AD26DDFA",
    "patient_ID": "TCGA.C5.A2LY",
    "bcr_drug_barcode": "TCGA-C5-A2LY-D21305",
    "bcr_drug_uuid": "9DC32BEE-25A6-48D6-A582-A6E165A5813B",
    "form_completion_date": "2012-2-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "drug_cycles": 6,
    "drug_units": "MG/M2/WK",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "12427B02-6E3F-461C-B271-6AB230F628E7",
    "patient_ID": "TCGA.C5.A3HD",
    "bcr_drug_barcode": "TCGA-C5-A3HD-D30835",
    "bcr_drug_uuid": "C267EDF4-0C73-4C1D-96C6-355B2287ADA9",
    "form_completion_date": "2012-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "D626A732-AF64-4DEC-B4BF-3CB761BF4C8D",
    "patient_ID": "TCGA.C5.A7CH",
    "bcr_drug_barcode": "TCGA-C5-A7CH-D56511",
    "bcr_drug_uuid": "797AE99C-E4D4-4EDE-8E29-0A8F3A1BE314",
    "form_completion_date": "2014-2-11",
    "pharmaceutical_tx_ongoing_indicator": false
  },
  {
    "bcr_patient_uuid": "F8F470D2-924F-41DD-92C5-516B0BF68E44",
    "patient_ID": "TCGA.C5.A7CJ",
    "bcr_drug_barcode": "TCGA-C5-A7CJ-D56515",
    "bcr_drug_uuid": "1AACD955-9EB2-4DFA-BA7A-89FD85626A3E",
    "form_completion_date": "2014-2-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62
  },
  {
    "bcr_patient_uuid": "1C48393E-7DE9-42F6-A6F0-2CBFB8359316",
    "patient_ID": "TCGA.C5.A7CK",
    "bcr_drug_barcode": "TCGA-C5-A7CK-D56517",
    "bcr_drug_uuid": "BFECC70B-9153-4C18-94FB-E3CC92E38501",
    "form_completion_date": "2014-2-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 50
  },
  {
    "bcr_patient_uuid": "BAE2AF5E-484A-44F7-AD6B-66137CDAE300",
    "patient_ID": "TCGA.C5.A7CL",
    "bcr_drug_barcode": "TCGA-C5-A7CL-D56981",
    "bcr_drug_uuid": "271171D5-3179-4158-AE53-56A570CA3C73",
    "form_completion_date": "2014-2-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D223FF09-B80B-4368-9D80-A59DFBE4D820",
    "patient_ID": "TCGA.C5.A7CM",
    "bcr_drug_barcode": "TCGA-C5-A7CM-D56984",
    "bcr_drug_uuid": "CD77064F-E9A7-42BE-B00B-4932416F1705",
    "form_completion_date": "2014-2-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 84,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FF3808E4-EECE-4046-819B-FE1019317F8E",
    "patient_ID": "TCGA.C5.A7CO",
    "bcr_drug_barcode": "TCGA-C5-A7CO-D56985",
    "bcr_drug_uuid": "120E8710-FFBF-48B1-8C5B-676E7B0E3876",
    "form_completion_date": "2014-2-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DA30A845-C4D3-4C78-B8B0-210239224F8F",
    "patient_ID": "TCGA.C5.A7UE",
    "bcr_drug_barcode": "TCGA-C5-A7UE-D57027",
    "bcr_drug_uuid": "F8C24E83-C9C1-48FC-B371-0CCDD3B809F0",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8328925E-3324-4188-85F1-6FFBF819D9E7",
    "patient_ID": "TCGA.C5.A7UH",
    "bcr_drug_barcode": "TCGA-C5-A7UH-D57021",
    "bcr_drug_uuid": "984C0FC8-5951-46F4-AF25-B8163F38204D",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 18,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4ED1616E-8C62-4104-BCBE-26D7059F04D0",
    "patient_ID": "TCGA.C5.A7X3",
    "bcr_drug_barcode": "TCGA-C5-A7X3-D56994",
    "bcr_drug_uuid": "C7862EF2-080F-499E-92D3-840E034090A5",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "CISPLATINUM",
    "clinical_trial_drug_classification": "CISPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 26,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4ED1616E-8C62-4104-BCBE-26D7059F04D0",
    "patient_ID": "TCGA.C5.A7X3",
    "bcr_drug_barcode": "TCGA-C5-A7X3-D56995",
    "bcr_drug_uuid": "319CE21B-32D0-4C7F-944E-E8EEFC7BB2A6",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "5-FLUROURACIL",
    "clinical_trial_drug_classification": "5-FLUROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 26,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4ED1616E-8C62-4104-BCBE-26D7059F04D0",
    "patient_ID": "TCGA.C5.A7X3",
    "bcr_drug_barcode": "TCGA-C5-A7X3-D56996",
    "bcr_drug_uuid": "601CC8EB-C647-4BFB-930E-09527D09BDE9",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "AMIFOSTINE",
    "clinical_trial_drug_classification": "AMIFOSTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 16,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "AED93A3A-7DCB-4BA9-84C0-BC735CBD545F",
    "patient_ID": "TCGA.C5.A7X5",
    "bcr_drug_barcode": "TCGA-C5-A7X5-D56988",
    "bcr_drug_uuid": "03521B1B-810A-4BE9-9B34-207EE2D821DC",
    "form_completion_date": "2014-2-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AED93A3A-7DCB-4BA9-84C0-BC735CBD545F",
    "patient_ID": "TCGA.C5.A7X5",
    "bcr_drug_barcode": "TCGA-C5-A7X5-D56989",
    "bcr_drug_uuid": "07EDF1F2-521E-473D-B227-ED8038C74D39",
    "form_completion_date": "2014-2-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 93,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 202,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "57902B91-BE42-441D-8807-A5EA9C21B214",
    "patient_ID": "TCGA.C5.A7X8",
    "bcr_drug_barcode": "TCGA-C5-A7X8-D57044",
    "bcr_drug_uuid": "5D6C5633-842A-4C8C-9FC6-7C9489484FEA",
    "form_completion_date": "2014-2-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "959FE574-054A-4FEF-9CBE-A801A9A355DE",
    "patient_ID": "TCGA.C5.A8XI",
    "bcr_drug_barcode": "TCGA-C5-A8XI-D58650",
    "bcr_drug_uuid": "BCB7C41F-67F7-4B56-8448-39B7D7C61C9B",
    "form_completion_date": "2014-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 205,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E89D0CB1-6EC2-43EE-A6D9-B922B680AF34",
    "patient_ID": "TCGA.C5.A8XJ",
    "bcr_drug_barcode": "TCGA-C5-A8XJ-D58645",
    "bcr_drug_uuid": "3FCF68B3-E355-4DA0-9C94-B6149603DF9A",
    "form_completion_date": "2014-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 77,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8AC819B3-4227-4EAE-BE03-8760B197DF9A",
    "patient_ID": "TCGA.C5.A8XK",
    "bcr_drug_barcode": "TCGA-C5-A8XK-D58139",
    "bcr_drug_uuid": "3690C830-6E5E-4FA9-8B13-65AB49B74002",
    "form_completion_date": "2014-4-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DE3CFB81-25C3-4137-8F24-AD8AA607C158",
    "patient_ID": "TCGA.C5.A8YQ",
    "bcr_drug_barcode": "TCGA-C5-A8YQ-D58639",
    "bcr_drug_uuid": "ED687F1B-1E47-4D1B-AF20-7C902B7766E3",
    "form_completion_date": "2014-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 214,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CECAECB4-51EF-407D-A882-0E4B444B0A77",
    "patient_ID": "TCGA.C5.A8YT",
    "bcr_drug_barcode": "TCGA-C5-A8YT-D58633",
    "bcr_drug_uuid": "023568BE-29CA-47DC-A39F-9E562969725B",
    "form_completion_date": "2014-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33BC6504-D9AB-4B64-A87C-012915F36644",
    "patient_ID": "TCGA.C5.A8ZZ",
    "bcr_drug_barcode": "TCGA-C5-A8ZZ-D58625",
    "bcr_drug_uuid": "13436EC9-48A3-4CEB-9EFE-93F42CB6EA2D",
    "form_completion_date": "2014-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "010A807F-9DC0-4E14-9533-DCF478F3D947",
    "patient_ID": "TCGA.C5.A902",
    "bcr_drug_barcode": "TCGA-C5-A902-D58629",
    "bcr_drug_uuid": "ED865073-B057-42DB-9EA8-5D0B20B591E9",
    "form_completion_date": "2014-4-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C92696BA-F549-480D-8D4A-5F23B27AA336",
    "patient_ID": "TCGA.C5.A907",
    "bcr_drug_barcode": "TCGA-C5-A907-D58147",
    "bcr_drug_uuid": "A838B6D3-A560-4453-A856-6B9D1170211F",
    "form_completion_date": "2014-4-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7C93642D-7E05-40F8-B1EF-A014EDCFBA42",
    "patient_ID": "TCGA.DG.A2KJ",
    "bcr_drug_barcode": "TCGA-DG-A2KJ-D58846",
    "bcr_drug_uuid": "FDC804FE-9CBF-44F9-BAD5-F9056C21DD23",
    "form_completion_date": "2014-4-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 145,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175
  },
  {
    "bcr_patient_uuid": "8DBCB17D-0396-4FAA-9B32-8E2566424BFF",
    "patient_ID": "TCGA.DG.A2KK",
    "bcr_drug_barcode": "TCGA-DG-A2KK-D49823",
    "bcr_drug_uuid": "C7F19426-0D49-41B9-AF8D-EBE3FA652802",
    "form_completion_date": "2013-10-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149
  },
  {
    "bcr_patient_uuid": "2DA977FC-8B46-4C40-9636-B12FD36A98E4",
    "patient_ID": "TCGA.DG.A2KL",
    "bcr_drug_barcode": "TCGA-DG-A2KL-D61036",
    "bcr_drug_uuid": "DE7C7E8A-DFA5-4D71-9D40-1A65B07AA599",
    "form_completion_date": "2014-6-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 141,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E87FADBE-C58C-41D1-B413-8CF6CE70CE94",
    "patient_ID": "TCGA.DG.A2KM",
    "bcr_drug_barcode": "TCGA-DG-A2KM-D49780",
    "bcr_drug_uuid": "EA657419-8880-44EF-9936-5476962614BA",
    "form_completion_date": "2013-10-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155
  },
  {
    "bcr_patient_uuid": "748aada0-448f-4523-9893-3d9618fdbe18",
    "patient_ID": "TCGA.DR.A0ZM",
    "bcr_drug_barcode": "TCGA-DR-A0ZM-D17118",
    "bcr_drug_uuid": "D926B906-4EC1-4D19-974E-E852936E646C",
    "form_completion_date": "2011-3-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 6,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "5ed3c95a-10d0-4cd5-a54d-523e81587fb1",
    "patient_ID": "TCGA.DS.A0VK",
    "bcr_drug_barcode": "TCGA-DS-A0VK-D8640",
    "bcr_drug_uuid": "e74bdcd2-ccde-4ffd-96f8-9707f96b17c4",
    "form_completion_date": "2011-3-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 209,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 398,
    "drug_cycles": 6,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 588,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 3528
  },
  {
    "bcr_patient_uuid": "ed6d989d-da09-4818-8fed-f33d88b628af",
    "patient_ID": "TCGA.DS.A0VM",
    "bcr_drug_barcode": "TCGA-DS-A0VM-D8642",
    "bcr_drug_uuid": "1d3da5d7-7c94-4ba8-961d-d37ec233d318",
    "form_completion_date": "2011-3-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 30,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 120
  },
  {
    "bcr_patient_uuid": "f8d342f5-9b92-42e1-8b0d-0876cc26965d",
    "patient_ID": "TCGA.DS.A0VN",
    "bcr_drug_barcode": "TCGA-DS-A0VN-D8738",
    "bcr_drug_uuid": "c2d25fd5-44c6-400a-8857-33092a62271c",
    "form_completion_date": "2011-3-4",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 68,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 340
  },
  {
    "bcr_patient_uuid": "46c67dd6-8e66-411d-ad05-95daa9005eb2",
    "patient_ID": "TCGA.DS.A1OA",
    "bcr_drug_barcode": "TCGA-DS-A1OA-D15318",
    "bcr_drug_uuid": "1C316E84-6CA7-434F-BE32-6A8AEE5B89A9",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 758,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 786,
    "drug_cycles": 3,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1200,
    "regimen_number": 5,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 3600
  },
  {
    "bcr_patient_uuid": "46c67dd6-8e66-411d-ad05-95daa9005eb2",
    "patient_ID": "TCGA.DS.A1OA",
    "bcr_drug_barcode": "TCGA-DS-A1OA-D15180",
    "bcr_drug_uuid": "72D1CA7A-6404-463A-B036-A3AB953DAE03",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 423,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 596,
    "drug_cycles": 14,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 14600
  },
  {
    "bcr_patient_uuid": "46c67dd6-8e66-411d-ad05-95daa9005eb2",
    "patient_ID": "TCGA.DS.A1OA",
    "bcr_drug_barcode": "TCGA-DS-A1OA-D15181",
    "bcr_drug_uuid": "7798FE45-492F-423C-B95A-100F4A4BE5A8",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 607,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 682,
    "drug_cycles": 8,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 35,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "STABLE/PERSISTENT",
    "drug_total_dose": 275
  },
  {
    "bcr_patient_uuid": "46c67dd6-8e66-411d-ad05-95daa9005eb2",
    "patient_ID": "TCGA.DS.A1OA",
    "bcr_drug_barcode": "TCGA-DS-A1OA-D15182",
    "bcr_drug_uuid": "EE9F6CF1-BC40-4073-A3AD-390DACD90E15",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "XELODA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 702,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 702,
    "drug_cycles": 1,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 14000,
    "regimen_number": 4,
    "drug_route": "ORAL",
    "therapy_regimen": "OTHER",
    "therapy_regimen_other": "STABLE/PERSISTENT",
    "drug_total_dose": 14000
  },
  {
    "bcr_patient_uuid": "46c67dd6-8e66-411d-ad05-95daa9005eb2",
    "patient_ID": "TCGA.DS.A1OA",
    "bcr_drug_barcode": "TCGA-DS-A1OA-D15179",
    "bcr_drug_uuid": "F3F96461-3EEB-4FE9-9B1A-7B6C71D1D4CB",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 150,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 750
  },
  {
    "bcr_patient_uuid": "29a48c93-bade-4346-a901-de35a6537337",
    "patient_ID": "TCGA.DS.A1OB",
    "bcr_drug_barcode": "TCGA-DS-A1OB-D20935",
    "bcr_drug_uuid": "7A4F7393-7B23-4A22-A621-AC7A98C0AB8F",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 675,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 710,
    "drug_cycles": 6,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1.5,
    "regimen_number": 2,
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 1008
  },
  {
    "bcr_patient_uuid": "29a48c93-bade-4346-a901-de35a6537337",
    "patient_ID": "TCGA.DS.A1OB",
    "bcr_drug_barcode": "TCGA-DS-A1OB-D20936",
    "bcr_drug_uuid": "4A846040-97B3-454E-A090-73D8365E21CF",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 675,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 710,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 2,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "RECURRENCE",
    "drug_total_dose": 660
  },
  {
    "bcr_patient_uuid": "29a48c93-bade-4346-a901-de35a6537337",
    "patient_ID": "TCGA.DS.A1OB",
    "bcr_drug_barcode": "TCGA-DS-A1OB-D20938",
    "bcr_drug_uuid": "EB18139A-43D7-4750-A63E-307C69FB7F89",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "IRINOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 784,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 800,
    "drug_cycles": 2,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 60,
    "regimen_number": 4,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 200
  },
  {
    "bcr_patient_uuid": "29a48c93-bade-4346-a901-de35a6537337",
    "patient_ID": "TCGA.DS.A1OB",
    "bcr_drug_barcode": "TCGA-DS-A1OB-D20933",
    "bcr_drug_uuid": "D77BC3EB-E2ED-4F2E-9745-CC8A783CCA61",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "29a48c93-bade-4346-a901-de35a6537337",
    "patient_ID": "TCGA.DS.A1OB",
    "bcr_drug_barcode": "TCGA-DS-A1OB-D20934",
    "bcr_drug_uuid": "1CEA0147-C6E4-4882-9525-206987056730",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "drug_cycles": 3,
    "regimen_number": 1,
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "29a48c93-bade-4346-a901-de35a6537337",
    "patient_ID": "TCGA.DS.A1OB",
    "bcr_drug_barcode": "TCGA-DS-A1OB-D20937",
    "bcr_drug_uuid": "E42B0F05-014E-43DA-B1F9-063B4E5E0C28",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 745,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 765,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 300,
    "regimen_number": 3,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1500
  },
  {
    "bcr_patient_uuid": "29a48c93-bade-4346-a901-de35a6537337",
    "patient_ID": "TCGA.DS.A1OB",
    "bcr_drug_barcode": "TCGA-DS-A1OB-D20939",
    "bcr_drug_uuid": "37C3D41D-9AF7-4B0A-84D2-94254659365C",
    "form_completion_date": "2012-1-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 784,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 800,
    "drug_cycles": 2,
    "drug_units": "AUC",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1.7,
    "regimen_number": 4,
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 400
  },
  {
    "bcr_patient_uuid": "e711b88e-fa0e-4781-8549-7a53ed3a13a1",
    "patient_ID": "TCGA.DS.A1OC",
    "bcr_drug_barcode": "TCGA-DS-A1OC-D15191",
    "bcr_drug_uuid": "98AB3883-AF06-4239-BC79-D7D1BC76FBD7",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 252,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 332,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 7080
  },
  {
    "bcr_patient_uuid": "e711b88e-fa0e-4781-8549-7a53ed3a13a1",
    "patient_ID": "TCGA.DS.A1OC",
    "bcr_drug_barcode": "TCGA-DS-A1OC-D15190",
    "bcr_drug_uuid": "0B4D1E76-9AEA-4129-8E9B-AD0843B068D4",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 252,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 332,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 50,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 360
  },
  {
    "bcr_patient_uuid": "ec609ebe-2db9-4b95-a154-512fdfa9038f",
    "patient_ID": "TCGA.DS.A1OD",
    "bcr_drug_barcode": "TCGA-DS-A1OD-D15186",
    "bcr_drug_uuid": "5FF927AF-D6B8-41A8-984D-219DC466B2A9",
    "form_completion_date": "2011-8-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "drug_cycles": 4,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 70,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 280
  },
  {
    "bcr_patient_uuid": "63BFFDB1-BC08-4175-8BE7-D7A056D19816",
    "patient_ID": "TCGA.DS.A3LQ",
    "bcr_drug_barcode": "TCGA-DS-A3LQ-D31100",
    "bcr_drug_uuid": "64E076D2-EC46-4033-B991-A5716A6D19A7",
    "form_completion_date": "2012-4-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 40,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 427
  },
  {
    "bcr_patient_uuid": "B16469AF-A721-43E9-A4D7-C39B94D1139F",
    "patient_ID": "TCGA.DS.A5RQ",
    "bcr_drug_barcode": "TCGA-DS-A5RQ-D43181",
    "bcr_drug_uuid": "20A70A61-B65B-4EE9-BA68-1B3738C291A3",
    "form_completion_date": "2013-5-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 63,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D02FFAA9-0403-4A89-BE01-CCE35C80DD69",
    "patient_ID": "TCGA.DS.A7WF",
    "bcr_drug_barcode": "TCGA-DS-A7WF-D54752",
    "bcr_drug_uuid": "6BBFFE71-CD5D-4340-89B0-709C35F6FA63",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 397,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DADCF6D5-03EB-4090-BCC3-B9E9DC3C7E08",
    "patient_ID": "TCGA.DS.A7WH",
    "bcr_drug_barcode": "TCGA-DS-A7WH-D54774",
    "bcr_drug_uuid": "77253106-F449-4E19-800E-3EB594A38AD4",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 112,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C14468EB-E725-4029-96CC-75BB9EBD9DEF",
    "patient_ID": "TCGA.DS.A7WI",
    "bcr_drug_barcode": "TCGA-DS-A7WI-D54772",
    "bcr_drug_uuid": "7D8F75F1-23CB-44C0-B948-3494D6D754CE",
    "form_completion_date": "2013-12-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 108,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9E2E29E8-D94A-499F-A98A-5B53B2C38F3B",
    "patient_ID": "TCGA.EA.A3QD",
    "bcr_drug_barcode": "TCGA-EA-A3QD-D58164",
    "bcr_drug_uuid": "342CF8C0-1020-45FF-9C5C-D96128CB5368",
    "form_completion_date": "2014-4-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3265F9C1-7242-4C7D-B4AD-B6519EE94F84",
    "patient_ID": "TCGA.EA.A43B",
    "bcr_drug_barcode": "TCGA-EA-A43B-D58725",
    "bcr_drug_uuid": "43CFF346-D800-4B3C-A1D3-FCF8590970A9",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3265F9C1-7242-4C7D-B4AD-B6519EE94F84",
    "patient_ID": "TCGA.EA.A43B",
    "bcr_drug_barcode": "TCGA-EA-A43B-D58726",
    "bcr_drug_uuid": "BD1405B3-FE04-4F41-8E66-1F933D432F75",
    "form_completion_date": "2014-4-22",
    "pharmaceutical_therapy_drug_name": "5-FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CFB61FD8-0BCA-40B4-878C-CC914A289792",
    "patient_ID": "TCGA.EA.A44S",
    "bcr_drug_barcode": "TCGA-EA-A44S-D49901",
    "bcr_drug_uuid": "354F8B4C-1002-4F0A-B507-FAD0C8C1C3A5",
    "form_completion_date": "2013-10-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CFB61FD8-0BCA-40B4-878C-CC914A289792",
    "patient_ID": "TCGA.EA.A44S",
    "bcr_drug_barcode": "TCGA-EA-A44S-D49902",
    "bcr_drug_uuid": "051D1E1E-D001-4288-B8F9-C4119DC36A1A",
    "form_completion_date": "2013-10-14",
    "pharmaceutical_therapy_drug_name": "BLEOMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 20,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CFB61FD8-0BCA-40B4-878C-CC914A289792",
    "patient_ID": "TCGA.EA.A44S",
    "bcr_drug_barcode": "TCGA-EA-A44S-D49903",
    "bcr_drug_uuid": "D4AEB293-B03B-47C2-A043-2EF0415A0447",
    "form_completion_date": "2013-10-14",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 299,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CFB61FD8-0BCA-40B4-878C-CC914A289792",
    "patient_ID": "TCGA.EA.A44S",
    "bcr_drug_barcode": "TCGA-EA-A44S-D49905",
    "bcr_drug_uuid": "B4FFE834-F2D2-4DB7-8EF5-4FD29B245D21",
    "form_completion_date": "2013-10-14",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 299,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CFB61FD8-0BCA-40B4-878C-CC914A289792",
    "patient_ID": "TCGA.EA.A44S",
    "bcr_drug_barcode": "TCGA-EA-A44S-D49907",
    "bcr_drug_uuid": "C564DE36-51A0-4F7B-AE3D-900803489E96",
    "form_completion_date": "2013-10-14",
    "pharmaceutical_therapy_drug_name": "BLEOMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 299,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 369,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9E79059F-3453-4AA6-9849-55A267C711A4",
    "patient_ID": "TCGA.EA.A4BA",
    "bcr_drug_barcode": "TCGA-EA-A4BA-D49909",
    "bcr_drug_uuid": "18657CF1-F5AA-48A1-BAB8-1B511F341EA4",
    "form_completion_date": "2013-10-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9E79059F-3453-4AA6-9849-55A267C711A4",
    "patient_ID": "TCGA.EA.A4BA",
    "bcr_drug_barcode": "TCGA-EA-A4BA-D49910",
    "bcr_drug_uuid": "1780B434-014B-456D-9F14-298A819FC3EB",
    "form_completion_date": "2013-10-14",
    "pharmaceutical_therapy_drug_name": "CYCLOPHOSPHAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9E79059F-3453-4AA6-9849-55A267C711A4",
    "patient_ID": "TCGA.EA.A4BA",
    "bcr_drug_barcode": "TCGA-EA-A4BA-D49911",
    "bcr_drug_uuid": "B4F30A70-2AB7-4FA1-888B-AC1E7096ACAC",
    "form_completion_date": "2013-10-14",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 134,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C83C52F4-3815-4F49-8218-CF80AAA62E2F",
    "patient_ID": "TCGA.EK.A2H0",
    "bcr_drug_barcode": "TCGA-EK-A2H0-D31970",
    "bcr_drug_uuid": "3CF33478-3029-494E-AE79-DF669875863C",
    "form_completion_date": "2012-5-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "690A7B2A-7DC5-4504-9372-70C8B55E81C7",
    "patient_ID": "TCGA.EK.A2H1",
    "bcr_drug_barcode": "TCGA-EK-A2H1-D21355",
    "bcr_drug_uuid": "47D3FA29-395F-42C6-9004-5FE997C50FD9",
    "form_completion_date": "2012-2-10",
    "pharmaceutical_therapy_drug_name": "CETUXIMAB",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "drug_cycles": 1,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 400,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 640
  },
  {
    "bcr_patient_uuid": "61EB08D0-EA01-45E7-884B-AC3D6070172A",
    "patient_ID": "TCGA.EK.A2RL",
    "bcr_drug_barcode": "TCGA-EK-A2RL-D58212",
    "bcr_drug_uuid": "74B640D3-522E-4D42-9C30-BA9132FDE318",
    "form_completion_date": "2014-4-2",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 912,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 968,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F5D90810-8C4B-4CED-9360-383E42CB54B3",
    "patient_ID": "TCGA.EX.A3L1",
    "bcr_drug_barcode": "TCGA-EX-A3L1-D38133",
    "bcr_drug_uuid": "D5445E7B-B1F0-466E-9421-73072DDC7669",
    "form_completion_date": "2012-12-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "EB0EB159-732E-43FF-A402-7F2D9F67DAA8",
    "patient_ID": "TCGA.EX.A449",
    "bcr_drug_barcode": "TCGA-EX-A449-D47410",
    "bcr_drug_uuid": "F031D1DD-20A0-4CFE-93B8-51E09B7099EC",
    "form_completion_date": "2013-8-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 47,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 109,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EB0EB159-732E-43FF-A402-7F2D9F67DAA8",
    "patient_ID": "TCGA.EX.A449",
    "bcr_drug_barcode": "TCGA-EX-A449-D47412",
    "bcr_drug_uuid": "1CA76EBB-F1FB-4769-BE88-45DF8439B867",
    "form_completion_date": "2013-8-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EB0EB159-732E-43FF-A402-7F2D9F67DAA8",
    "patient_ID": "TCGA.EX.A449",
    "bcr_drug_barcode": "TCGA-EX-A449-D47413",
    "bcr_drug_uuid": "6D6F9C3B-74AC-4E3B-8DEF-41396B7471D1",
    "form_completion_date": "2013-8-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "86731af9-2d33-4521-9cf9-5f6152ca15d7",
    "patient_ID": "TCGA.FU.A23L",
    "bcr_drug_barcode": "TCGA-FU-A23L-D56155",
    "bcr_drug_uuid": "74452C14-7355-4AD6-958B-BCB5BF4E44E9",
    "form_completion_date": "2014-1-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 80,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "674E010C-7AD4-4DC2-86B0-284CD4560633",
    "patient_ID": "TCGA.FU.A3HY",
    "bcr_drug_barcode": "TCGA-FU-A3HY-D64211",
    "bcr_drug_uuid": "6B9972B5-AE6C-4658-BA1B-30CDE0D8C214",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 60,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6FF12A54-10DA-4941-BFEA-7B66E19B4BE9",
    "patient_ID": "TCGA.FU.A3HZ",
    "bcr_drug_barcode": "TCGA-FU-A3HZ-D64229",
    "bcr_drug_uuid": "11063673-DD72-418C-8090-19921AB04C0C",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6868BA1D-B612-454C-8146-74AF2F573D76",
    "patient_ID": "TCGA.FU.A3WB",
    "bcr_drug_barcode": "TCGA-FU-A3WB-D64235",
    "bcr_drug_uuid": "7C60D850-1A5A-45EF-BF33-1DA000A277BA",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6868BA1D-B612-454C-8146-74AF2F573D76",
    "patient_ID": "TCGA.FU.A3WB",
    "bcr_drug_barcode": "TCGA-FU-A3WB-D64236",
    "bcr_drug_uuid": "80E759F8-CE9D-4730-A538-D10A3C87F4C7",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "ALOXI",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 116,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "63DCFA32-C69E-45AD-BEA3-AE672ACB11C6",
    "patient_ID": "TCGA.FU.A40J",
    "bcr_drug_barcode": "TCGA-FU-A40J-D64220",
    "bcr_drug_uuid": "7ADAFA1B-FAE9-4369-A13A-0D7734550AC0",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 306,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "63DCFA32-C69E-45AD-BEA3-AE672ACB11C6",
    "patient_ID": "TCGA.FU.A40J",
    "bcr_drug_barcode": "TCGA-FU-A40J-D64221",
    "bcr_drug_uuid": "CB60C6D5-AFC3-4B83-9DBF-D649951043AF",
    "form_completion_date": "2014-8-27",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 104,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 306,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E2FF7CFD-A101-45B9-895F-26F403E7BDFB",
    "patient_ID": "TCGA.HG.A2PA",
    "bcr_drug_barcode": "TCGA-HG-A2PA-D33512",
    "bcr_drug_uuid": "EE17B0E2-CE3E-43C0-80C9-57134F94BA7C",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E2FF7CFD-A101-45B9-895F-26F403E7BDFB",
    "patient_ID": "TCGA.HG.A2PA",
    "bcr_drug_barcode": "TCGA-HG-A2PA-D33513",
    "bcr_drug_uuid": "D5B1F254-E5C8-48D9-9402-A558837BF830",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CF87812F-6DB6-4592-9842-C62B3E4FF03F",
    "patient_ID": "TCGA.HG.A9SC",
    "bcr_drug_barcode": "TCGA-HG-A9SC-D60991",
    "bcr_drug_uuid": "64D96D07-DE09-491B-8668-3102380DA868",
    "form_completion_date": "2014-6-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F150D999-CDEC-427E-B8B2-00731C648989",
    "patient_ID": "TCGA.HM.A3JJ",
    "bcr_drug_barcode": "TCGA-HM-A3JJ-D29258",
    "bcr_drug_uuid": "801FEF42-121B-46DF-ABD7-6CCECA54F4D8",
    "form_completion_date": "2012-3-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 110,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 70,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "7C4CD55F-750E-4941-A9F3-0632A75D6531",
    "patient_ID": "TCGA.HM.A3JK",
    "bcr_drug_barcode": "TCGA-HM-A3JK-D21788",
    "bcr_drug_uuid": "8143DAE6-E257-403E-BB9D-38884E600FF7",
    "form_completion_date": "2012-2-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "drug_cycles": 5,
    "drug_units": "MG",
    "drug_tota_dose_units": "MG",
    "drug_dose": 70,
    "regimen_number": 1,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 350
  },
  {
    "bcr_patient_uuid": "6BCF8B41-7ABC-4B6F-899A-1F67B4ADA765",
    "patient_ID": "TCGA.HM.A4S6",
    "bcr_drug_barcode": "TCGA-HM-A4S6-D42760",
    "bcr_drug_uuid": "D3B2B9D8-5887-4271-8C20-F368C42E0097",
    "form_completion_date": "2013-4-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 223,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 243,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "929505F7-0270-475E-A9D6-00BF38DC78BA",
    "patient_ID": "TCGA.HM.A6W2",
    "bcr_drug_barcode": "TCGA-HM-A6W2-D50249",
    "bcr_drug_uuid": "B41660FF-ED31-4FF2-B0DD-57253CB818F8",
    "form_completion_date": "2013-10-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 85,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 120,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "66229DD6-C771-4455-A90C-C66FB40CF7FE",
    "patient_ID": "TCGA.IR.A3L7",
    "bcr_drug_barcode": "TCGA-IR-A3L7-D38291",
    "bcr_drug_uuid": "99356D52-C28E-407A-A29D-E5A1088525CE",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7B8C04D7-824D-493D-8F2C-9ED87A907192",
    "patient_ID": "TCGA.IR.A3LA",
    "bcr_drug_barcode": "TCGA-IR-A3LA-D39484",
    "bcr_drug_uuid": "879222E5-1EFD-4436-A977-13BB90006308",
    "form_completion_date": "2013-1-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7B8C04D7-824D-493D-8F2C-9ED87A907192",
    "patient_ID": "TCGA.IR.A3LA",
    "bcr_drug_barcode": "TCGA-IR-A3LA-D39485",
    "bcr_drug_uuid": "B61E901D-3B92-401F-AC6A-999C175C46A5",
    "form_completion_date": "2013-1-24",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL (5-FU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7C7783C-1D0F-4F42-A4CF-518825E91D91",
    "patient_ID": "TCGA.IR.A3LB",
    "bcr_drug_barcode": "TCGA-IR-A3LB-D39501",
    "bcr_drug_uuid": "7E1FA50E-B5AD-448C-8001-B6D877993913",
    "form_completion_date": "2013-1-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 138,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7C7783C-1D0F-4F42-A4CF-518825E91D91",
    "patient_ID": "TCGA.IR.A3LB",
    "bcr_drug_barcode": "TCGA-IR-A3LB-D39503",
    "bcr_drug_uuid": "2DAC5EBB-CAE7-49CB-A810-509E31040F63",
    "form_completion_date": "2013-1-24",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL (5-FU)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 72,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7C7783C-1D0F-4F42-A4CF-518825E91D91",
    "patient_ID": "TCGA.IR.A3LB",
    "bcr_drug_barcode": "TCGA-IR-A3LB-D39505",
    "bcr_drug_uuid": "F04625F9-2C4F-4B6F-944D-C730D8BB68AC",
    "form_completion_date": "2013-1-24",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 500,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7C7783C-1D0F-4F42-A4CF-518825E91D91",
    "patient_ID": "TCGA.IR.A3LB",
    "bcr_drug_barcode": "TCGA-IR-A3LB-D39507",
    "bcr_drug_uuid": "694F1C43-677B-4B42-AB0F-DF306C5C99EA",
    "form_completion_date": "2013-1-24",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 363,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 500,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "58BDCACE-0047-456E-A225-68953EDAFE5E",
    "patient_ID": "TCGA.IR.A3LC",
    "bcr_drug_barcode": "TCGA-IR-A3LC-D38296",
    "bcr_drug_uuid": "A95DAC18-6883-4A30-9E1E-27551C9445B7",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F24ED9C0-92BB-4003-86D2-42AB26617A05",
    "patient_ID": "TCGA.IR.A3LH",
    "bcr_drug_barcode": "TCGA-IR-A3LH-D38301",
    "bcr_drug_uuid": "3D3105F8-BC2E-4485-B58F-96DDF1DB8EE8",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 148,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 183,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75BC22D8-738D-45F8-B6C0-C664F5FEF47C",
    "patient_ID": "TCGA.IR.A3LI",
    "bcr_drug_barcode": "TCGA-IR-A3LI-D38329",
    "bcr_drug_uuid": "6FD64D29-1926-459E-B5DA-816D3F97CCFE",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75BC22D8-738D-45F8-B6C0-C664F5FEF47C",
    "patient_ID": "TCGA.IR.A3LI",
    "bcr_drug_barcode": "TCGA-IR-A3LI-D38330",
    "bcr_drug_uuid": "F1DBA871-99FD-4D4C-AB21-A146ACDE4608",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 73,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75BC22D8-738D-45F8-B6C0-C664F5FEF47C",
    "patient_ID": "TCGA.IR.A3LI",
    "bcr_drug_barcode": "TCGA-IR-A3LI-D38331",
    "bcr_drug_uuid": "01E813AD-1807-4B08-BC61-73BEB8C5C916",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN HCL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 211,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "75BC22D8-738D-45F8-B6C0-C664F5FEF47C",
    "patient_ID": "TCGA.IR.A3LI",
    "bcr_drug_barcode": "TCGA-IR-A3LI-D38332",
    "bcr_drug_uuid": "2FAF8699-6739-49AC-85ED-333A8BA1E0CF",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 211,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E",
    "patient_ID": "TCGA.IR.A3LK",
    "bcr_drug_barcode": "TCGA-IR-A3LK-D38335",
    "bcr_drug_uuid": "E502C966-183F-4170-A354-B67DE0DE5D91",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 101,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E",
    "patient_ID": "TCGA.IR.A3LK",
    "bcr_drug_barcode": "TCGA-IR-A3LK-D38336",
    "bcr_drug_uuid": "BAB25380-1F3B-440A-95A3-4698D5A3EC9C",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 598,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 707,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B79558C5-1DB2-4B1E-A7B8-EFBD19AA855E",
    "patient_ID": "TCGA.IR.A3LK",
    "bcr_drug_barcode": "TCGA-IR-A3LK-D38337",
    "bcr_drug_uuid": "8ADC65C5-06CD-4C1A-8D30-394CAA5648CB",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 598,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 707,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7C4AB1CA-4BDD-4EF7-9A42-F6C0C7136D26",
    "patient_ID": "TCGA.IR.A3LL",
    "bcr_drug_barcode": "TCGA-IR-A3LL-D38340",
    "bcr_drug_uuid": "04E0C6F4-594D-4A80-A45A-F15B5D290A01",
    "form_completion_date": "2012-12-14",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 48,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0BD52D75-5113-4EF1-BC75-509F59EAEF2B",
    "patient_ID": "TCGA.JW.A5VG",
    "bcr_drug_barcode": "TCGA-JW-A5VG-D58206",
    "bcr_drug_uuid": "907266E1-5423-4E3C-9C72-00B915F1BE87",
    "form_completion_date": "2014-4-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 26,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6813C53C-B256-4115-AD90-24D75328779E",
    "patient_ID": "TCGA.JW.A5VH",
    "bcr_drug_barcode": "TCGA-JW-A5VH-D46358",
    "bcr_drug_uuid": "1A8782DE-A9E9-4CE0-A472-584BE2B1272C",
    "form_completion_date": "2013-8-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 48,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6813C53C-B256-4115-AD90-24D75328779E",
    "patient_ID": "TCGA.JW.A5VH",
    "bcr_drug_barcode": "TCGA-JW-A5VH-D69368",
    "bcr_drug_uuid": "D7A732E4-CD7C-47F1-853A-26C9493EB66C",
    "form_completion_date": "2015-1-7",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 48,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "53EB4C4E-0719-476F-9B2B-279D438D7710",
    "patient_ID": "TCGA.JW.A5VI",
    "bcr_drug_barcode": "TCGA-JW-A5VI-D45006",
    "bcr_drug_uuid": "C5AD3DD1-DB8E-4106-97BE-4CA01A2B0480",
    "form_completion_date": "2013-10-16",
    "pharmaceutical_therapy_drug_name": "TOPOTECAN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 571,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 623,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E15D92A1-6925-4B58-A494-D6F665F67B83",
    "patient_ID": "TCGA.LP.A4AU",
    "bcr_drug_barcode": "TCGA-LP-A4AU-D58086",
    "bcr_drug_uuid": "17273461-E423-4C32-93D2-7A05ABAEDB1C",
    "form_completion_date": "2014-3-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E15D92A1-6925-4B58-A494-D6F665F67B83",
    "patient_ID": "TCGA.LP.A4AU",
    "bcr_drug_barcode": "TCGA-LP-A4AU-D58087",
    "bcr_drug_uuid": "36DCFD67-54B3-451B-BF22-25FE9393781B",
    "form_completion_date": "2014-3-31",
    "pharmaceutical_therapy_drug_name": "5FU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 91,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FC2BCE29-4685-49F5-B901-2117BF673BB8",
    "patient_ID": "TCGA.MA.AA3W",
    "bcr_drug_barcode": "TCGA-MA-AA3W-D64865",
    "bcr_drug_uuid": "DE131EAB-9290-4833-8513-3BA191FBDDDC",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ADB7C5C8-4AFD-40DC-89F1-571FBD88E4F9",
    "patient_ID": "TCGA.MA.AA3X",
    "bcr_drug_barcode": "TCGA-MA-AA3X-D64892",
    "bcr_drug_uuid": "10F27E3D-3267-4B36-A08A-A46F8A6D8FD0",
    "form_completion_date": "2014-9-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CEF2EFB2-93CC-4BDF-A343-9965E7E0432C",
    "patient_ID": "TCGA.MY.A5BD",
    "bcr_drug_barcode": "TCGA-MY-A5BD-D67175",
    "bcr_drug_uuid": "6E4581C1-EB5C-493C-8EEC-E6B8ECE74BB5",
    "form_completion_date": "2014-10-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4F4E8834-A716-42E6-BD51-60D80A619202",
    "patient_ID": "TCGA.MY.A5BF",
    "bcr_drug_barcode": "TCGA-MY-A5BF-D67173",
    "bcr_drug_uuid": "F8BD8AE2-4E5B-4FC7-895D-D907C6A45730",
    "form_completion_date": "2014-10-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 188,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C9F519B6-73F1-4737-83CB-F5EF208592CD",
    "patient_ID": "TCGA.MY.A913",
    "bcr_drug_barcode": "TCGA-MY-A913-D59733",
    "bcr_drug_uuid": "6CFF5264-76FD-43DC-87CB-9C01433D42E3",
    "form_completion_date": "2014-5-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 30,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 79,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "55ADD854-E63F-4335-BEA9-23C3EB1E766A",
    "patient_ID": "TCGA.PN.A8MA",
    "bcr_drug_barcode": "TCGA-PN-A8MA-D57802",
    "bcr_drug_uuid": "0BA1607D-3682-49B1-A7AB-F5CF48525262",
    "form_completion_date": "2014-5-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 48,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F3CBADB3-3B83-47CD-B8A0-B0E10343A295",
    "patient_ID": "TCGA.Q1.A5R2",
    "bcr_drug_barcode": "TCGA-Q1-A5R2-D48279",
    "bcr_drug_uuid": "56934D77-B222-4F09-B296-CCA334AAD2D7",
    "form_completion_date": "2013-9-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 48,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "73AA428A-4288-45F8-8A53-CEC173DCC61F",
    "patient_ID": "TCGA.Q1.A5R3",
    "bcr_drug_barcode": "TCGA-Q1-A5R3-D48282",
    "bcr_drug_uuid": "C5C29ED4-F72E-4232-ACC3-915430D476E6",
    "form_completion_date": "2013-9-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 56,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5DBD5436-696E-40FA-881B-C2386573AC68",
    "patient_ID": "TCGA.Q1.A6DW",
    "bcr_drug_barcode": "TCGA-Q1-A6DW-D46940",
    "bcr_drug_uuid": "B5C77B18-F27A-4CC5-9CF8-6107E83AAFDB",
    "form_completion_date": "2013-8-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "D0CBE668-5C95-4261-A1E8-CEF55093A0F7",
    "patient_ID": "TCGA.Q1.A73O",
    "bcr_drug_barcode": "TCGA-Q1-A73O-D50840",
    "bcr_drug_uuid": "0CBEB31F-1EFD-41EB-8D76-26FF440332EA",
    "form_completion_date": "2013-10-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5C72BDA2-2EC0-455F-AB27-7247FD5FFFF9",
    "patient_ID": "TCGA.Q1.A73Q",
    "bcr_drug_barcode": "TCGA-Q1-A73Q-D50823",
    "bcr_drug_uuid": "9AAD51FE-13BD-4BFC-BE91-D2006570638D",
    "form_completion_date": "2013-10-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 45,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "B0F63819-FC86-4981-9D92-0115C6DE3BCE",
    "patient_ID": "TCGA.Q1.A73S",
    "bcr_drug_barcode": "TCGA-Q1-A73S-D50813",
    "bcr_drug_uuid": "5017EAAD-0177-496C-A6DB-E916EE13386D",
    "form_completion_date": "2013-10-31",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 42,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "0E137272-A21C-4C5E-BFD1-A774B339A753",
    "patient_ID": "TCGA.R2.A69V",
    "bcr_drug_barcode": "TCGA-R2-A69V-D58931",
    "bcr_drug_uuid": "20E60A9F-1F04-4860-9614-D90A6622C0AC",
    "form_completion_date": "2014-5-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN-XRT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BDAD2F13-EDE2-4AAD-91A4-BF60F8888BF2",
    "patient_ID": "TCGA.RA.A741",
    "bcr_drug_barcode": "TCGA-RA-A741-D51218",
    "bcr_drug_uuid": "CA996310-983C-4D64-A2A3-1AD4558A97F2",
    "form_completion_date": "2013-11-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 254,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BDAD2F13-EDE2-4AAD-91A4-BF60F8888BF2",
    "patient_ID": "TCGA.RA.A741",
    "bcr_drug_barcode": "TCGA-RA-A741-D51219",
    "bcr_drug_uuid": "27032B2D-9885-4398-B8E1-82EF7C0D1194",
    "form_completion_date": "2013-11-13",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 254,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BDAD2F13-EDE2-4AAD-91A4-BF60F8888BF2",
    "patient_ID": "TCGA.RA.A741",
    "bcr_drug_barcode": "TCGA-RA-A741-D56699",
    "bcr_drug_uuid": "B52F8D6F-C07A-453C-A246-B713967195E8",
    "form_completion_date": "2014-2-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 9,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 76,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BDAD2F13-EDE2-4AAD-91A4-BF60F8888BF2",
    "patient_ID": "TCGA.RA.A741",
    "bcr_drug_barcode": "TCGA-RA-A741-D66182",
    "bcr_drug_uuid": "E0AD8182-60F5-46E5-8B7E-C8623125249C",
    "form_completion_date": "2014-10-3",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 233,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 254,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "53D99A89-6EBD-4637-91DB-7CE43EBC6B8B",
    "patient_ID": "TCGA.UC.A7PG",
    "bcr_drug_barcode": "TCGA-UC-A7PG-D61868",
    "bcr_drug_uuid": "DB97B514-17D5-4D9A-9C22-0896A63486ED",
    "form_completion_date": "2014-7-17",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AFB5442E-0249-475B-8F82-CAE4E0268AD1",
    "patient_ID": "TCGA.VS.A8EC",
    "bcr_drug_barcode": "TCGA-VS-A8EC-D61977",
    "bcr_drug_uuid": "E92C9CD5-FA20-429C-9D02-ED80C876D1CB",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 430,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 617,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AFB5442E-0249-475B-8F82-CAE4E0268AD1",
    "patient_ID": "TCGA.VS.A8EC",
    "bcr_drug_barcode": "TCGA-VS-A8EC-D62009",
    "bcr_drug_uuid": "922C203B-1B73-4D57-906F-518241AC938B",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 430,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 617,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "05026179-B1DA-411E-A286-89727B1AE380",
    "patient_ID": "TCGA.VS.A8EH",
    "bcr_drug_barcode": "TCGA-VS-A8EH-D62772",
    "bcr_drug_uuid": "6AA03F28-F6A9-444D-86FF-1E86AA069F1A",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 67,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 88,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7B228C3B-E604-41A1-9B76-8DD3D5A59FFE",
    "patient_ID": "TCGA.VS.A8EI",
    "bcr_drug_barcode": "TCGA-VS-A8EI-D64588",
    "bcr_drug_uuid": "9081E806-69F2-43F6-8E10-E6D99C3BACD3",
    "form_completion_date": "2014-9-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 47,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2E08A89E-4035-4782-B54F-F98EEF5DB80D",
    "patient_ID": "TCGA.VS.A8EJ",
    "bcr_drug_barcode": "TCGA-VS-A8EJ-D62775",
    "bcr_drug_uuid": "D2AD658E-3F2A-48BD-82EE-431A683B66BE",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2E08A89E-4035-4782-B54F-F98EEF5DB80D",
    "patient_ID": "TCGA.VS.A8EJ",
    "bcr_drug_barcode": "TCGA-VS-A8EJ-D62776",
    "bcr_drug_uuid": "908D2796-3195-4448-8BD1-72E85523306F",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 322,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2E08A89E-4035-4782-B54F-F98EEF5DB80D",
    "patient_ID": "TCGA.VS.A8EJ",
    "bcr_drug_barcode": "TCGA-VS-A8EJ-D62777",
    "bcr_drug_uuid": "D2D50CB6-E465-45B9-A255-2178CEC9FE12",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "FLUORURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 169,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 322,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D9C2CA21-F1A6-4CF4-BE28-6C2492DD38E5",
    "patient_ID": "TCGA.VS.A8EK",
    "bcr_drug_barcode": "TCGA-VS-A8EK-D62778",
    "bcr_drug_uuid": "4608A3B1-2585-4E69-8194-33D9CA824C35",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E0A5D99B-B58B-4301-B2DC-A767D90059B1",
    "patient_ID": "TCGA.VS.A8EL",
    "bcr_drug_barcode": "TCGA-VS-A8EL-D64589",
    "bcr_drug_uuid": "B38CCD33-80D7-4EDA-B3C7-28F024DC880D",
    "form_completion_date": "2014-9-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CB695FDD-381E-4C00-836E-0BA27E32176B",
    "patient_ID": "TCGA.VS.A8QC",
    "bcr_drug_barcode": "TCGA-VS-A8QC-D61994",
    "bcr_drug_uuid": "31286449-EDE9-4BC3-ADA7-30943A71494A",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "21254CB0-68F3-4ECC-8D9A-73FB0E994C5B",
    "patient_ID": "TCGA.VS.A8QF",
    "bcr_drug_barcode": "TCGA-VS-A8QF-D62000",
    "bcr_drug_uuid": "E09A597F-8072-47C3-BAA2-520E63D22AAA",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 118,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C4F61715-EE58-4799-A5F4-0F5E27C4093D",
    "patient_ID": "TCGA.VS.A8QH",
    "bcr_drug_barcode": "TCGA-VS-A8QH-D62005",
    "bcr_drug_uuid": "BBB1806B-37D4-4DAD-BA0D-870901A18049",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C4F61715-EE58-4799-A5F4-0F5E27C4093D",
    "patient_ID": "TCGA.VS.A8QH",
    "bcr_drug_barcode": "TCGA-VS-A8QH-D65297",
    "bcr_drug_uuid": "D1392037-BB2A-4CF5-8421-BE274E5395F2",
    "form_completion_date": "2014-9-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "27D2B645-F1BF-4486-B0B5-273681B58625",
    "patient_ID": "TCGA.VS.A8QM",
    "bcr_drug_barcode": "TCGA-VS-A8QM-D61947",
    "bcr_drug_uuid": "5079FF1A-2F4B-4088-8168-7A3A3042489A",
    "form_completion_date": "2014-7-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 136,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "27D2B645-F1BF-4486-B0B5-273681B58625",
    "patient_ID": "TCGA.VS.A8QM",
    "bcr_drug_barcode": "TCGA-VS-A8QM-D65296",
    "bcr_drug_uuid": "1C0DBDC1-83FA-4B53-A402-A48ABA89A4B4",
    "form_completion_date": "2014-9-21",
    "pharmaceutical_therapy_drug_name": "FLUOROURACIL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 81,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2F6A0E87-1E6C-41F3-93E0-3E505FA654B0",
    "patient_ID": "TCGA.VS.A94W",
    "bcr_drug_barcode": "TCGA-VS-A94W-D70275",
    "bcr_drug_uuid": "D1241E75-98C5-4EE9-AC69-D282F12CAE1D",
    "form_completion_date": "2015-2-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "240EF385-DECC-48F7-A798-A81B4AB0410E",
    "patient_ID": "TCGA.VS.A94X",
    "bcr_drug_barcode": "TCGA-VS-A94X-D62787",
    "bcr_drug_uuid": "85118345-207B-43EC-A69C-E16BD65A1EA5",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 64,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0E7F79CD-D188-42EA-BF96-4BA9E9B8606B",
    "patient_ID": "TCGA.VS.A94Y",
    "bcr_drug_barcode": "TCGA-VS-A94Y-D62789",
    "bcr_drug_uuid": "6D107EBB-1755-4A7C-9A3A-21A49777DDFB",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 95,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "69BABA9F-19C2-4947-95DC-0DD3412929BA",
    "patient_ID": "TCGA.VS.A94Z",
    "bcr_drug_barcode": "TCGA-VS-A94Z-D62793",
    "bcr_drug_uuid": "138D8801-6CD9-43F9-B8D3-1FB6FB9BF29A",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 80,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9BA72A77-AEF0-4788-8072-60C28902E55D",
    "patient_ID": "TCGA.VS.A954",
    "bcr_drug_barcode": "TCGA-VS-A954-D62797",
    "bcr_drug_uuid": "31C84693-FA3B-435F-8746-78CEA4D4B89F",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 94,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CB31B3CE-8595-4D75-9436-BB59E95C3A19",
    "patient_ID": "TCGA.VS.A957",
    "bcr_drug_barcode": "TCGA-VS-A957-D62800",
    "bcr_drug_uuid": "FE43C9DF-DCCC-4A9A-B4E6-05BD6260167D",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 140,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "97CF3268-9756-4659-9E98-F200F96A91F4",
    "patient_ID": "TCGA.VS.A958",
    "bcr_drug_barcode": "TCGA-VS-A958-D62804",
    "bcr_drug_uuid": "4B8E9E37-3369-4E1F-9D37-45B1B326F4A0",
    "form_completion_date": "2014-7-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "939ABCA1-8BD0-4271-9A9B-666764EEB3B6",
    "patient_ID": "TCGA.VS.A9U5",
    "bcr_drug_barcode": "TCGA-VS-A9U5-D63439",
    "bcr_drug_uuid": "EF658883-3A46-4E6C-8256-6A45287BD55E",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 36,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 71,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "98784BBE-E286-48DF-838D-1A88040658BF",
    "patient_ID": "TCGA.VS.A9U6",
    "bcr_drug_barcode": "TCGA-VS-A9U6-D63446",
    "bcr_drug_uuid": "BDE69B17-53CF-4220-96CA-A9006A4A466E",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D01421E-D533-4967-8422-97FBC0FB0895",
    "patient_ID": "TCGA.VS.A9U7",
    "bcr_drug_barcode": "TCGA-VS-A9U7-D63460",
    "bcr_drug_uuid": "188BFB3C-D196-47B2-9C99-4FACCD06ADE7",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 192,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 220,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "60117B70-36C0-41BB-A9FC-85DB8FA10102",
    "patient_ID": "TCGA.VS.A9UA",
    "bcr_drug_barcode": "TCGA-VS-A9UA-D63477",
    "bcr_drug_uuid": "B1D0877D-E150-40BF-AD5F-ACB4BBEAC36D",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 118,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 162,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CA242B4C-B879-4E13-A1E7-84C984067189",
    "patient_ID": "TCGA.VS.A9UB",
    "bcr_drug_barcode": "TCGA-VS-A9UB-D65878",
    "bcr_drug_uuid": "107F4992-511B-4946-8096-D16382E92606",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CCA23650-1B06-4977-91E8-F35E73E70C48",
    "patient_ID": "TCGA.VS.A9UC",
    "bcr_drug_barcode": "TCGA-VS-A9UC-D63478",
    "bcr_drug_uuid": "C0D9120A-6CA4-4746-997B-0B828C421848",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 203,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "60CFA29F-4770-4EE4-AA37-787F53155662",
    "patient_ID": "TCGA.VS.A9UD",
    "bcr_drug_barcode": "TCGA-VS-A9UD-D63434",
    "bcr_drug_uuid": "535F5BEE-B950-4EE1-89A0-C45F7565B1B7",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6949C03E-067A-49A5-B48D-E9380A1B0B27",
    "patient_ID": "TCGA.VS.A9UH",
    "bcr_drug_barcode": "TCGA-VS-A9UH-D63870",
    "bcr_drug_uuid": "5ECDA20A-D998-4660-A6B2-F178C7B054EE",
    "form_completion_date": "2014-8-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 90,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 133,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EE2C9743-EAA1-4F0D-8D35-E96686AC3913",
    "patient_ID": "TCGA.VS.A9UM",
    "bcr_drug_barcode": "TCGA-VS-A9UM-D64650",
    "bcr_drug_uuid": "5E4A789E-39EA-4751-A2C1-1CE33311769B",
    "form_completion_date": "2014-9-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 423,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 459,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EE2C9743-EAA1-4F0D-8D35-E96686AC3913",
    "patient_ID": "TCGA.VS.A9UM",
    "bcr_drug_barcode": "TCGA-VS-A9UM-D64654",
    "bcr_drug_uuid": "3B0630CF-E2D6-4CFE-B50C-B5938FFA47C7",
    "form_completion_date": "2014-9-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EE2C9743-EAA1-4F0D-8D35-E96686AC3913",
    "patient_ID": "TCGA.VS.A9UM",
    "bcr_drug_barcode": "TCGA-VS-A9UM-D64655",
    "bcr_drug_uuid": "4F2F9A4B-B3AF-4690-B6AB-F0E62933E730",
    "form_completion_date": "2014-9-9",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4DA121DA-9193-4AC5-8206-03CB1F7C2C14",
    "patient_ID": "TCGA.VS.A9UO",
    "bcr_drug_barcode": "TCGA-VS-A9UO-D63484",
    "bcr_drug_uuid": "7DF378B9-E2A9-41C7-BCF8-FFE5A356565D",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 52,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 69,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F0CFAACC-30E5-4E54-B33A-F0FD5DAD620E",
    "patient_ID": "TCGA.VS.A9UP",
    "bcr_drug_barcode": "TCGA-VS-A9UP-D63458",
    "bcr_drug_uuid": "82CD6A7E-AD39-4A38-A53F-0AD1EABE3268",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 119,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ADC60720-AC20-4E73-9C37-3AD3119C07D6",
    "patient_ID": "TCGA.VS.A9UR",
    "bcr_drug_barcode": "TCGA-VS-A9UR-D63470",
    "bcr_drug_uuid": "5160FB3B-17E6-47A9-B589-32D895E197B2",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 45,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4770EC81-9174-4D2A-AF54-70C00696FB0B",
    "patient_ID": "TCGA.VS.A9UU",
    "bcr_drug_barcode": "TCGA-VS-A9UU-D65893",
    "bcr_drug_uuid": "96F43D49-0111-4847-BC76-553F3DD390C3",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 57,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A1B99260-8643-4CEF-95A0-3853D64762B7",
    "patient_ID": "TCGA.VS.A9UY",
    "bcr_drug_barcode": "TCGA-VS-A9UY-D64585",
    "bcr_drug_uuid": "47D7D03D-BCC9-4123-AE5B-71157465604C",
    "form_completion_date": "2014-9-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 6,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 34,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A5885835-9473-455A-BAC0-6FA43FA8A866",
    "patient_ID": "TCGA.VS.A9V0",
    "bcr_drug_barcode": "TCGA-VS-A9V0-D65886",
    "bcr_drug_uuid": "F3AA1D6F-478C-4EAB-A251-42884E286649",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 144,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A6A07BC7-AB1B-429D-81ED-D7A890C88E51",
    "patient_ID": "TCGA.VS.A9V1",
    "bcr_drug_barcode": "TCGA-VS-A9V1-D64593",
    "bcr_drug_uuid": "70591F56-179A-43E5-BC9C-587884B78384",
    "form_completion_date": "2014-9-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 21,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 49,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1CB1D2CA-DFA6-4C42-9DA9-C711DC5AAB5D",
    "patient_ID": "TCGA.VS.A9V3",
    "bcr_drug_barcode": "TCGA-VS-A9V3-D63454",
    "bcr_drug_uuid": "BA99CD4B-A6DE-4981-A47C-FB8A203105F1",
    "form_completion_date": "2014-8-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 96,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "778389BA-C2E9-47D4-B133-6F4D0E689B34",
    "patient_ID": "TCGA.VS.A9V4",
    "bcr_drug_barcode": "TCGA-VS-A9V4-D63703",
    "bcr_drug_uuid": "DCD18A3F-9FC6-43E2-8376-4A4E7D24C11C",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 79,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 107,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D3FF2AEB-46BE-4F54-8A8F-178EB921FBB6",
    "patient_ID": "TCGA.VS.A9V5",
    "bcr_drug_barcode": "TCGA-VS-A9V5-D65882",
    "bcr_drug_uuid": "502961DD-9C7F-4032-BED4-F6E20D29702F",
    "form_completion_date": "2014-10-1",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 89,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 124,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "173174F8-9D95-40B0-9F88-A4BF4CCB521B",
    "patient_ID": "TCGA.VS.AA62",
    "bcr_drug_barcode": "TCGA-VS-AA62-D68117",
    "bcr_drug_uuid": "98AE48EA-B27C-4014-8A6C-E1759052C4A4",
    "form_completion_date": "2014-11-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 34,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 64,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "48D81B1E-CD75-4B55-A0B2-C331BE2A88AE",
    "patient_ID": "TCGA.WL.A834",
    "bcr_drug_barcode": "TCGA-WL-A834-D57161",
    "bcr_drug_uuid": "8DFC71FE-774C-44C3-A87B-0B7EA8DBCE27",
    "form_completion_date": "2014-6-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "48D81B1E-CD75-4B55-A0B2-C331BE2A88AE",
    "patient_ID": "TCGA.WL.A834",
    "bcr_drug_barcode": "TCGA-WL-A834-D57162",
    "bcr_drug_uuid": "F7763EE1-727F-4DC9-815E-8C90D2949DD2",
    "form_completion_date": "2014-6-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "48D81B1E-CD75-4B55-A0B2-C331BE2A88AE",
    "patient_ID": "TCGA.WL.A834",
    "bcr_drug_barcode": "TCGA-WL-A834-D59852",
    "bcr_drug_uuid": "C4A9B575-CD38-4852-9E4E-DEA6B8843115",
    "form_completion_date": "2014-6-19",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 61,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "FFD8D31F-BC4B-4E19-BBAF-0E26E9F3A107",
    "patient_ID": "TCGA.XS.A8TJ",
    "bcr_drug_barcode": "TCGA-XS-A8TJ-D63711",
    "bcr_drug_uuid": "B4F2E7FC-3BE4-456A-9C73-7E967A8E4987",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FFD8D31F-BC4B-4E19-BBAF-0E26E9F3A107",
    "patient_ID": "TCGA.XS.A8TJ",
    "bcr_drug_barcode": "TCGA-XS-A8TJ-D63712",
    "bcr_drug_uuid": "350F7016-7FBD-47FB-B090-E4F49213D592",
    "form_completion_date": "2014-8-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 155,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B12DEB95-6AA1-49CB-A3C5-A711D42D6FB9",
    "patient_ID": "TCGA.ZJ.A8QQ",
    "bcr_drug_barcode": "TCGA-ZJ-A8QQ-D56891",
    "bcr_drug_uuid": "D9393162-CBD7-4C44-926C-6511920A4C85",
    "form_completion_date": "2014-2-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "therapy_on_clinical_trial": true
  }
]
